Chlorine in PDB 2weh: Thermodynamic Optimisation of Carbonic Anhydrase Fragment Inhibitors

Enzymatic activity of Thermodynamic Optimisation of Carbonic Anhydrase Fragment Inhibitors

All present enzymatic activity of Thermodynamic Optimisation of Carbonic Anhydrase Fragment Inhibitors:
4.2.1.1;

Protein crystallography data

The structure of Thermodynamic Optimisation of Carbonic Anhydrase Fragment Inhibitors, PDB code: 2weh was solved by A.D.Scott, C.Phillips, A.Alex, A.Bent, R.O'brien, L.Damian, L.H.Jones, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

*Resolution Low / High (Å)*	20.31 / 2.10
*Space group*	P 1 2₁ 1
*Cell size a, b, c (Å), α, β, γ (°)*	42.432, 41.223, 72.038, 90.00, 104.26, 90.00
*R / R_free (%)*	16.5 / 24.1

Other elements in 2weh:

The structure of Thermodynamic Optimisation of Carbonic Anhydrase Fragment Inhibitors also contains other interesting chemical elements:

Zinc

(Zn)

1 atom

Chlorine Binding Sites:

The binding sites of Chlorine atom in the Thermodynamic Optimisation of Carbonic Anhydrase Fragment Inhibitors (pdb code 2weh). This binding sites where shown within 5.0 Angstroms radius around Chlorine atom.
In total only one binding site of Chlorine was determined in the Thermodynamic Optimisation of Carbonic Anhydrase Fragment Inhibitors, PDB code: 2weh:

Chlorine binding site 1 out of 1 in 2weh

Go back to

Chlorine Binding Sites List in 2weh

Chlorine binding site 1 out of 1 in the Thermodynamic Optimisation of Carbonic Anhydrase Fragment Inhibitors

Mono view

Stereo pair view

A full contact list of Chlorine with other atoms in the Cl binding site number 1 of Thermodynamic Optimisation of Carbonic Anhydrase Fragment Inhibitors within 5.0Å range:

probe	atom	residue	distance (Å)	B	Occ
A:Cl1263 b:18.7 occ:1.00	CL1	A:FB11263	0.0	18.7	1.0
	C6	A:FB11263	1.7	13.6	1.0
	C5	A:FB11263	2.6	13.7	1.0
	C1	A:FB11263	2.6	14.2	1.0
	O2	A:FB11263	3.1	11.7	1.0
	S	A:FB11263	3.2	10.7	1.0
	O1	A:FB11263	3.2	7.2	1.0
	CG2	A:VAL143	3.3	3.2	1.0
	CD1	A:LEU141	3.6	4.6	1.0
	CG1	A:VAL121	3.7	2.7	1.0
	CD1	A:LEU198	3.9	6.7	1.0
	C4	A:FB11263	3.9	15.9	1.0
	C2	A:FB11263	3.9	19.4	1.0
	CG2	A:VAL121	4.0	2.0	1.0
	CG	A:LEU198	4.2	10.1	1.0
	C3	A:FB11263	4.4	18.5	1.0
	CB	A:VAL121	4.5	6.0	1.0
	CG2	A:VAL207	4.5	6.6	1.0
	CB	A:VAL143	4.7	5.3	1.0
	CA	A:LEU198	4.7	6.3	1.0
	N	A:FB11263	4.8	9.8	1.0
	CG1	A:VAL143	4.8	4.8	1.0
	CB	A:LEU198	4.9	7.1	1.0
	CG	A:LEU141	5.0	8.4	1.0

Reference:

A.D.Scott, C.Phillips, A.Alex, M.Flocco, A.Bent, A.Randall, R.O'brien, L.Damian, L.H.Jones. Thermodynamic Optimisation in Drug Discovery: A Case Study Using Carbonic Anhydrase Inhibitors. Chemmedchem V. 4 1985 2009.
ISSN: ISSN 1860-7179
PubMed: 19882701
DOI: 10.1002/CMDC.200900386

Page generated: Sat Jul 20 12:43:53 2024

Last articles

Zn in 9MJ5
Zn in 9HNW
Zn in 9G0L
Zn in 9FNE
Zn in 9DZN
Zn in 9E0I
Zn in 9D32
Zn in 9DAK
Zn in 8ZXC
Zn in 8ZUF

	© Copyright 2008-2020 by atomistry.com
Home \| Site Map \| Copyright \| Contact us \| Privacy